Olah, C., Tschirdewahn, S., Hoffmann, M. J., Krafft, U., Hadaschik, B., Nyirady, P., . . . Szarvas, T. (2020). Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients. Diagnostics (Basel).
Dyfyniad Arddull ChicagoOlah, Csilla, et al. "Soluble Syndecan-1 Levels Are Associated With Survival in Platinum-Treated Bladder Cancer Patients." Diagnostics (Basel) 2020.
Dyfyniad MLAOlah, Csilla, et al. "Soluble Syndecan-1 Levels Are Associated With Survival in Platinum-Treated Bladder Cancer Patients." Diagnostics (Basel) 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.